Patients are well served by Collis gastroplasty when indicated

Background Debate persists about the impact of a Collis gastroplasty on outcomes of antireflux operation. This study analyzed operative and quality of life outcomes from a series of 480 patients who underwent laparoscopic antireflux operation with a Collis gastroplasty reported to date. Methods A retrospective review was conducted to compare outcomes between patients undergoing laparoscopic antireflux operation with Collis gastroplasty versus without Collis gastroplasty at 2 large, foregut centers from October 2004 to December 2011 and July 2012 to September 2016. Demographic, perioperative, and quality of life data were reviewed. Four validated surveys were used to evaluate quality of life outcomes: the reflux symptom index, the gastroesophageal reflux disease health-related quality of life, the laryngopharyngeal reflux health-related quality of life, and the swallowing quality of life survey. Results The 480 patients consisted of 149 patients with a Collis gastroplasty versus 331 without a Collis gastroplasty (non-Collis) with mean age of 66.3 vs 58.9 years ( P ≤ .001), body mass index of 28.6 vs 29.7 ( P = .040), and an American Society for Anesthesiologists score of 2.4 vs 2.2 ( P = .005). Collis patients underwent operations of greater duration (133.2 vs 94.2 minutes; P ≤ .001) with greater duration of hospital stay (3.1 vs 1.8 days; P ≤ .001). Thirty-day readmission rates and wound-related complications were equivalent between the 2 groups. After a mean of 12 months follow-up, quality of life assessment revealed significant improvements for all postoperative patients with comparable results between Collis and non-Collis patients. Furthermore, the addition of a Collis gastroplasty did not contribute to postoperative dysphagia, reflux, or the leak rate. Conclusion Patients who require a Collis gastroplasty to address a true short esophagus during laparoscopic antireflux operation have comparable operative and quality of life benefits as non-Collis patients, without added morbidity or mortality.